TELA Bio (TELA) Invested Capital (2018 - 2026)

TELA Bio has reported Invested Capital for 9 years, with the latest figure at $40.2 million in Q2 2026.

• On a quarterly basis, Invested Capital fell 20.47% year-over-year to $40.2 million in Q2 2026; TTM through Jun 2026 was $40.2 million, a 20.47% decrease from a year earlier, with the FY2025 full-year figure at $62.0 million, down 10.95% from the prior year.
• Invested Capital was $40.2 million for Q2 2026 at TELA Bio, down from $50.7 million in the prior quarter.
• The five-year high for Invested Capital was $80.2 million in Q2 2023, with the low at $34.7 million in Q3 2024.
• Average Invested Capital over 5 years is $53.3 million, with a median of $52.4 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Invested Capital soared 110.68% in 2023, then slumped 51.07% in 2024.
• Over 5 years, Invested Capital stood at $54.2 million in 2022, then climbed by 9.54% to $59.4 million in 2023, then grew by 17.15% to $69.6 million in 2024, then declined by 10.95% to $62.0 million in 2025, then slumped by 35.1% to $40.2 million in 2026.
• The last three Invested Capital figures came in at $40.2 million (Q2 2026), $50.7 million (Q1 2026), and $62.0 million (Q4 2025), per Business Quant data.